C-reactive protein as a marker of cardiovascular disease in patients with a schizophrenia spectrum disorder treated in routine medical practice

Publication year: 2011 Source: European Psychiatry, Available online 1 October 2011 A. Sicras-Mainar, J. Rejas-Gutiérrez, R. Navarro-Artieda, M. Blanca-Tamayo ObjectiveInterest in cardiovascular diseases (CVD) in schizophrenia has grown recently due to documented incremental mortality.

Publication year: 2011 Source: European Psychiatry, Available online 1 October 2011 A. Sicras-Mainar, J. Rejas-Gutiérrez, R. Navarro-Artieda, M. Blanca-Tamayo ObjectiveInterest in cardiovascular diseases (CVD) in schizophrenia has grown recently due to documented incremental mortality.

See the article here:
C-reactive protein as a marker of cardiovascular disease in patients with a schizophrenia spectrum disorder treated in routine medical practice

Related posts:

  1. Characteristics of subjects with schizophrenia spectrum disorder with and without antipsychotic medication – A 10-year follow-up of the Northern…
  2. The deceleration capacity – a new measure of heart rate variability evaluated in patients with schizophrenia and antipsychotic treatment
  3. UK national survey of venous thromboembolism prophylaxis in ankle fracture patients treated with plaster casts
  4. Triple arthrodesis of the foot after calcaneal fractures. Twelve patients treated using K wires stabilization
  5. Functional outcome of ankle fracture patients treated with biodegradable implants
  6. Specialty Care Programme for autism spectrum disorders in an urban population: A case-management model for health care delivery in an ASD population
  7. Complex chromatin condensation patterns and nuclear protein transitions during spermiogenesis: Examples from mollusks
  8. Passenger mutations as a marker of clonal cell lineages in emerging neoplasia
  9. Forgetting what you have checked: A link between working memory impairment and checking behaviors in obsessive-compulsive disorder
  10. Screening for bipolar disorder among outpatients with substance use disorders